CN Patent
CN116782894A — 作为Kv1.3钾Shaker通道阻断剂的内酰胺化合物
Assigned to D E Xiao Research Co ltd · Expires 2023-09-19 · 3y expired
What this patent protects
描述了式(I)化合物或其药学上可接受的盐,其中取代基如本文所定义。还描述了包含它们的药物组合物,以及使用它们的方法。
USPTO Abstract
描述了式(I)化合物或其药学上可接受的盐,其中取代基如本文所定义。还描述了包含它们的药物组合物,以及使用它们的方法。
Drugs covered by this patent
- Briviact (BRIVARACETAM) · UCB
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.